Background Botulinum toxin (BTX) injection alone is not sufficient to treat spasticity in
children, notably those with cerebral palsy; thus, there is an emerging trend for adjunct …

The aim of this review was to assess the effectiveness of therapy interventions on improving
outcomes in children with cerebral palsy (CP) who have received botulinum toxin A (BTX-A) …

Abstract Background Adjunct therapies (ATs) may further improve outcomes after botulinum
toxin injections in spastic patients, but evidence was unclear in previous systematic reviews …

Background Spasticity is a common motor disorder in children with cerebral palsy (CP).
Upper limb CP impairment has a significant negative impact on daily activities. Botulinum …

Background: Cerebral palsy (CP) is the most common cause of childhood disability globally.
Botulinum toxin A injections are widely used to manage limb spasticity in children with CP …

Botulinum toxin type A (BoNT-A) therapy has gained wide acceptance in the management of
spasticity in cerebral palsy (CP). Clinical experience from numerous case reports and series …

BACKGROUND: To assess treatment effect of lower limb botulinum toxin type A (BTX-A) in
combination with physiotherapy approaches on gross motor functions in children with …

Objective: To determine the quality of evidence from randomized controlled trials on the
efficacy of adjunct therapies following botulinum toxin injections for limb spasticity. Data …

Aim The aim of this study was to determine the effects of repeat botulinum toxin A (Bo NT‐A)
injections in children with spastic cerebral palsy (CP) on the basis of a best evidence …

Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …